Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Rabinowitz

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Alpha Psychiatry|July 8, 2026
EEG Neurofeedback for Major Depressive Disorder: A Scoping ReviewDan Cătălin Oprea, Jonathan Rabinowitz, Bogdan Gireadă, et al.
The American Journal of Psychiatry|May 3, 2005
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trialNina Schooler, Jonathan Rabinowitz, Michael Davidson, et al.
Journal of Affective Disorders|October 21, 2023
Consistency checks to improve measurement with the Young Mania Rating Scale (YMRS)Jonathan Rabinowitz, Robert C Young, Christian Yavorsky, et al.
Archives of General Psychiatry|September 6, 2006
Advancing paternal age and autismAbraham Reichenberg, Raz Gross, Mark Weiser, et al.
Journal of Affective Disorders|February 1, 2022
Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D)Jonathan Rabinowitz, Janet B W Williams, Ariana Anderson, et al.
Journal of Affective Disorders|January 13, 2023
Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A)Jonathan Rabinowitz, Janet B W Williams, Nanco Hefting, et al.
Journal of Affective Disorders|June 9, 2019
Consistency checks to improve measurement with the Montgomery-Asberg Depression Rating Scale (MADRS)Jonathan Rabinowitz, Nina R Schooler, Brianne Brown, et al.
Schizophrenia Research|March 13, 2017
Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS)Jonathan Rabinowitz, Nina R Schooler, Ariana Anderson, et al.
Schizophrenia Research|September 14, 2013
Issues and perspectives in designing clinical trials for negative symptoms in schizophreniaStephen R Marder, Larry Alphs, Ion-George Anghelescu, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Alpha Psychiatry|July 8, 2026
EEG Neurofeedback for Major Depressive Disorder: A Scoping ReviewDan Cătălin Oprea, Jonathan Rabinowitz, Bogdan Gireadă, et al.
The American Journal of Psychiatry|May 3, 2005
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trialNina Schooler, Jonathan Rabinowitz, Michael Davidson, et al.
Journal of Affective Disorders|October 21, 2023
Consistency checks to improve measurement with the Young Mania Rating Scale (YMRS)Jonathan Rabinowitz, Robert C Young, Christian Yavorsky, et al.
Archives of General Psychiatry|September 6, 2006
Advancing paternal age and autismAbraham Reichenberg, Raz Gross, Mark Weiser, et al.
Journal of Affective Disorders|February 1, 2022
Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D)Jonathan Rabinowitz, Janet B W Williams, Ariana Anderson, et al.
Journal of Affective Disorders|January 13, 2023
Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A)Jonathan Rabinowitz, Janet B W Williams, Nanco Hefting, et al.
Journal of Affective Disorders|June 9, 2019
Consistency checks to improve measurement with the Montgomery-Asberg Depression Rating Scale (MADRS)Jonathan Rabinowitz, Nina R Schooler, Brianne Brown, et al.
Schizophrenia Research|March 13, 2017
Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS)Jonathan Rabinowitz, Nina R Schooler, Ariana Anderson, et al.
Schizophrenia Research|September 14, 2013
Issues and perspectives in designing clinical trials for negative symptoms in schizophreniaStephen R Marder, Larry Alphs, Ion-George Anghelescu, et al.
Pageof 11